HIGHLIGHTS
- who: Heidi Ryssel from the Faculty of Pharmaceutical Sciences, University of Su00e3o Paulo, Brazil have published the article: Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancer, in the Journal: (JOURNAL)
- what: The study is part of an interdisciplinary prospective observational trial, Immune-Mo (Immune function in patients undergoing immune modulating interventions), conducted in collaboration with PERSIMUNE, Centre of Excellence for Personalized Medicine of Infectious Complications in Immune Deficiency. This study shows evidence of chronic innate immune activation with high unstimulated ex vivo release of cytokines . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.